Tech Company Financing Transactions
ArsenalBio Funding Round
SoftBank Vision Fund, Bristol-Myers Squibb and Byers Capital invested in a $220 million Series B funding round for ArsenalBio. This VC investment round closed on 9/6/2022.
Transaction Overview
SoftBank Vision Fund (Lead Investor)
Kleiner Perkins Caufield & Byers (Brook Byers)
Parker Institute for Cancer Immunotherapy
UCSF Foundation Investment Company
University of California Berkeley
Westlake Village BioPartners (Beth Seidenberg)
Company Information
San Francisco, CA 94080
USA
Management Team
Browse more venture capital transactions:
Prev: 9/6/2022: Tailor K.K. venture capital transaction
Next: 9/7/2022: Spice AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs